Skip to content

Personalized functional connectivity guided rTMS treatment for adolescent patients with major depressive disorder

Personalized functional connectivity guided rTMS treatment for adolescent patients with major depressive disorder

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070984
Enrollment
Unknown
Registered
2023-04-27
Start date
2023-05-12
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDD

Interventions

Test group:A group of subjects received the "psychotherapy" intervention and the "anterior cingulate gyrus functional connectivity positioning" intervention, respectively, using an ABBA design to bala

Sponsors

The Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1)HAMD-17 > 17 points; (2)Meet the diagnostic criteria for depression in the International Classification of Diseases DSM-V, and be diagnosed with depression or bipolar disorder; (3)The current depressive episode was confirmed by the questionnaire of Emotional Disorders and schizophrenia in school-age children, KidDI-SADS Lifetime Edition (K-SADS-PL); (4)No gender limitation, age 12-18 years; (5)Subjects who are able to understand and willing to strictly follow the clinical trial protocol to complete the study, have informed consent from the guardian and can sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Contraindicated patients with MRI and TMS; (2)Severe physical and neurological disorders; (3)Schizophrenia, history of abuse of tobacco, alcohol and other psychoactive substances; (4)The patient is a pregnant or lactating woman or planning to become pregnant; (5)No immunomodulators and hormone preparations for at least half a year, no antipyretic and analgesic drugs for 2 weeks; (6) Those considered unsuitable for inclusion by researchers.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale, HAMD;Hamilton Anxiety Scale, HAMA;Theamplitudeof low-frequency fluctuations, ALFF;Functional connection, FC;reagional homogeneity, ReHo;

Secondary

MeasureTime frame
Snaith-Hamilton Pleasure Scale, SHAPS;Mood Disorder Questionnaire, MDQ;The Insomnia Severity index, ISI;Self-rating depression scale, SDS;the 21-item Depression Anxiety Stress Scale, DASS-21;Beck Scale for Suicide Ideation-Chinese Version, BSI- CV;Visual Analogue Score, VAS;

Countries

China

Contacts

Public ContactZang Yufeng

Hangzhou Normal University

zangyf@hznu.edu.cn+86 18606517380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026